Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SYRESYRE
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in SPYRE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.5M shares of SYRE (SPYRE THERAPEUTICS INC), worth $131.2M as of 2026-Q2. The position was increased (+447.6% shares). SYRE represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$131.2M

Current Shares

1.5M

Total Value Change

+$113.8M

Total Shares Change

+730,507

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+447.6%
$131.2M0.0%$88.78
49
2026-Q1
Decreased
269,938
-1.9%
$13.6M0.0%$40.07
0
2025-Q4
Decreased
275,065
-16.5%
$9M0.0%$31.88
0
2025-Q3
Decreased
329,533
-37.0%
$5.5M0.0%$16.36
0
2025-Q2
Increased
523,416
+165.6%
$7.8M0.0%$15.22
44
2025-Q1
Decreased
197,068
-73.6%
$3.2M0.0%$17.94
0
2024-Q4
New
747,552
-
$17.4M0.0%$22.54
39

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used